FLMVX
Price
$40.90
Change
-$0.17 (-0.41%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

FLMVX vs VMVAX

Header iconFLMVX vs VMVAX Comparison
Open Charts FLMVX vs VMVAXBanner chart's image
JPMorgan Mid Cap Value L
Price$40.90
Change-$0.17 (-0.41%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FLMVX vs VMVAX Comparison Chart
Loading...
VS
FLMVX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FLMVX is a Buy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. FLMVX (13.9B). VMVAX pays higher dividends than FLMVX: VMVAX (2.14) vs FLMVX (1.16). FLMVX was incepted earlier than VMVAX: FLMVX (27 years) vs VMVAX (13 years). VMVAX is a more actively managed with annual turnover of: 22.00 vs. FLMVX (12.00). VMVAX has a lower initial minimum investment than FLMVX: VMVAX (3000) vs FLMVX (3000000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. FLMVX (20.86). VMVAX return over 5 years is better than : 48.82 vs. FLMVX (9.20).
FLMVXVMVAXFLMVX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years13 years-
Gain YTD13.80114.94692%
Front LoadN/AN/A-
Min. Initial Investment30000003000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets13.9B30.5B46%
Annual Yield % from dividends1.162.1454%
Returns for 1 year20.8625.3582%
Returns for 3 years-4.6720.71-23%
Returns for 5 years9.2048.8219%
Returns for 10 years18.19100.8818%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio